Literature DB >> 29030856

Mitochondrial 3-Hydroxy-3-Methylglutaryl-CoA Synthase Deficiency: Unique Presenting Laboratory Values and a Review of Biochemical and Clinical Features.

Erin Conboy1,2, Filippo Vairo2, Matthew Schultz3, Katherine Agre1,2, Ross Ridsdale3, David Deyle1,2, Devin Oglesbee1,3, Dimitar Gavrilov1,2,3, Eric W Klee2, Brendan Lanpher4,5.   

Abstract

We report an 8-month-old infant with decreased consciousness after a febrile episode and reduced oral intake. He was profoundly acidotic but his lactate was normal. Serum triglycerides were markedly elevated and HDL cholesterol was very low. The urine organic acid analysis during the acute episode revealed a complex pattern of relative hypoketotic dicarboxylic aciduria, suggestive of a potential fatty acid oxidation disorder. MRI showed extensive brain abnormalities concerning for a primary energy deficiency. Whole exome sequencing revealed heterozygotic HMGCS2 variants. HMGCS2 encodes mitochondrial 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) synthase-2 (HMGCS2), which catalyzes the irreversible and rate-limiting reaction of ketogenesis in the mitochondrial matrix. Autosomal recessive HMG-CoA synthase deficiency (HMGCS2D) is characterized by hypoketotic hypoglycemia, vomiting, lethargy, and hepatomegaly after periods of prolonged fasting or illness. A retrospective analysis of the urine organic acid analysis identified 4-hydrox-6-methyl-2-pyrone, a recently reported putative biomarker of HMGCS2D. There was also a relative elevation of plasma acetylcarnitine as previously reported in one case. Our patient highlights a unique presentation of HMGCS2D caused by novel variants in HMGCS2. This is the first report of HMGCS2D with a significantly elevated triglyceride level and decreased HDL cholesterol level at presentation. Given this, we suggest that HMGCS2D should be considered in the differential diagnosis when hypertriglyceridemia, or low HDL cholesterol levels are seen in a child who presents with acidosis, mild ketosis, and mental status changes after illness or prolonged fasting. Although HMGCS2D is a rare disorder with nonspecific symptoms, with the advent of next-generation sequencing, and the recognition of novel biochemical biomarkers, the incidence of this condition may become better understood.

Entities:  

Keywords:  3-Hydroxy-3-methylglutaryl-CoA; HMG-CoA synthase; HMG-CoA synthase deficiency; HMGCS2; High-density lipoproteins; Hypertriglyceridemia

Year:  2017        PMID: 29030856      PMCID: PMC6122033          DOI: 10.1007/8904_2017_59

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  15 in total

1.  Fasting hypoketotic coma in a child with deficiency of mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase.

Authors:  G N Thompson; B Y Hsu; J J Pitt; E Treacy; C A Stanley
Journal:  N Engl J Med       Date:  1997-10-23       Impact factor: 91.245

2.  M-CAP eliminates a majority of variants of uncertain significance in clinical exomes at high sensitivity.

Authors:  Karthik A Jagadeesh; Aaron M Wenger; Mark J Berger; Harendra Guturu; Peter D Stenson; David N Cooper; Jonathan A Bernstein; Gill Bejerano
Journal:  Nat Genet       Date:  2016-10-24       Impact factor: 38.330

3.  MutationTaster2: mutation prediction for the deep-sequencing age.

Authors:  Jana Marie Schwarz; David N Cooper; Markus Schuelke; Dominik Seelow
Journal:  Nat Methods       Date:  2014-04       Impact factor: 28.547

4.  Genetic basis of mitochondrial HMG-CoA synthase deficiency.

Authors:  R Aledo; J Zschocke; J Pié; C Mir; S Fiesel; E Mayatepek; G F Hoffmann; N Casals; F G Hegardt
Journal:  Hum Genet       Date:  2001-07       Impact factor: 4.132

5.  Refining the diagnosis of mitochondrial HMG-CoA synthase deficiency.

Authors:  R Aledo; C Mir; R N Dalton; C Turner; J Pié; F G Hegardt; N Casals; M P Champion
Journal:  J Inherit Metab Dis       Date:  2006-02       Impact factor: 4.982

Review 6.  Mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase deficiency: urinary organic acid profiles and expanded spectrum of mutations.

Authors:  James J Pitt; Heidi Peters; Avihu Boneh; Joy Yaplito-Lee; Stefanie Wieser; Katrin Hinderhofer; David Johnson; Johannes Zschocke
Journal:  J Inherit Metab Dis       Date:  2014-12-16       Impact factor: 4.982

7.  Hepatic mitochondrial 3-hydroxy-3-methylglutaryl-coenzyme a synthase deficiency.

Authors:  A A Morris; C V Lascelles; S E Olpin; B D Lake; J V Leonard; P A Quant
Journal:  Pediatr Res       Date:  1998-09       Impact factor: 3.756

8.  A method and server for predicting damaging missense mutations.

Authors:  Ivan A Adzhubei; Steffen Schmidt; Leonid Peshkin; Vasily E Ramensky; Anna Gerasimova; Peer Bork; Alexey S Kondrashov; Shamil R Sunyaev
Journal:  Nat Methods       Date:  2010-04       Impact factor: 28.547

9.  The diagnosis of mitochondrial HMG-CoA synthase deficiency.

Authors:  Johannes Zschocke; Johannes M Penzien; Rainer Bielen; Núria Casals; Rosa Aledo; Juan Pié; Georg F Hoffmann; Fausto G Hegardt; Ertan Mayatepek
Journal:  J Pediatr       Date:  2002-06       Impact factor: 4.406

10.  Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Authors:  Sue Richards; Nazneen Aziz; Sherri Bale; David Bick; Soma Das; Julie Gastier-Foster; Wayne W Grody; Madhuri Hegde; Elaine Lyon; Elaine Spector; Karl Voelkerding; Heidi L Rehm
Journal:  Genet Med       Date:  2015-03-05       Impact factor: 8.822

View more
  11 in total

1.  Role of ketone signaling in the hepatic response to fasting.

Authors:  Caroline E Geisler; Susma Ghimire; Randy L Bogan; Benjamin J Renquist
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-02-15       Impact factor: 4.052

2.  Novel HMGCS2 pathogenic variants in a Chinese family with mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase deficiency.

Authors:  Pengfei Zhang; Xuyun Hu; Ruolan Guo; Jun Guo; Wei Li; Suyun Qian; Chanjuan Hao; Jun Liu
Journal:  Pediatr Investig       Date:  2019-06-25

3.  Human Mitochondrial HMG-CoA Synthase Deficiency: Role of Enzyme Dimerization Surface and Characterization of Three New Patients.

Authors:  Beatriz Puisac; Iñigo Marcos-Alcalde; María Hernández-Marcos; Pilar Tobajas Morlana; Alina Levtova; Bernd C Schwahn; Corinne DeLaet; Baiba Lace; Paulino Gómez-Puertas; Juan Pié
Journal:  Int J Mol Sci       Date:  2018-03-28       Impact factor: 5.923

4.  A Japanese case of mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase deficiency who presented with severe metabolic acidosis and fatty liver without hypoglycemia.

Authors:  Tomoko Lee; Yuichi Takami; Kenji Yamada; Hironori Kobayashi; Yuki Hasegawa; Hideo Sasai; Hiroki Otsuka; Yasuhiro Takeshima; Toshiyuki Fukao
Journal:  JIMD Rep       Date:  2019-06-03

5.  Severe clinical manifestation of mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase deficiency associated with two novel mutations: a case report.

Authors:  Hao Liu; Jing-Kun Miao; Chao-Wen Yu; Ke-Xing Wan; Juan Zhang; Zhao-Jian Yuan; Jing Yang; Dong-Juan Wang; Yan Zeng; Lin Zou
Journal:  BMC Pediatr       Date:  2019-10-09       Impact factor: 2.125

6.  The gene encoding the ketogenic enzyme HMGCS2 displays a unique expression during gonad development in mice.

Authors:  Stefan Bagheri-Fam; Huijun Chen; Sean Wilson; Katie Ayers; James Hughes; Frederique Sloan-Bena; Pierre Calvel; Gorjana Robevska; Beatriz Puisac; Kamila Kusz-Zamelczyk; Stefania Gimelli; Anna Spik; Jadwiga Jaruzelska; Alina Warenik-Szymankiewicz; Sultana Faradz; Serge Nef; Juan Pié; Paul Thomas; Andrew Sinclair; Dagmar Wilhelm
Journal:  PLoS One       Date:  2020-01-07       Impact factor: 3.240

Review 7.  A guide for the diagnosis of rare and undiagnosed disease: beyond the exome.

Authors:  Shruti Marwaha; Joshua W Knowles; Euan A Ashley
Journal:  Genome Med       Date:  2022-02-28       Impact factor: 15.266

8.  Clinical, Biochemical, Molecular, and Outcome Features of Mitochondrial 3-Hydroxy-3-Methylglutaryl-CoA Synthase Deficiency in 10 Chinese Patients.

Authors:  Shengnan Wu; Linghua Shen; Qiong Chen; Chunxiu Gong; Yanling Yang; Haiyan Wei; Bingyan Cao; Yongxing Chen
Journal:  Front Genet       Date:  2022-03-04       Impact factor: 4.599

9.  NMR-based metabolomic profile of hypercholesterolemic human sera: Relationship with in vitro gene expression?

Authors:  Manuela Grimaldi; Angelica Palisi; Carmen Marino; Paola Montoro; Anna Capasso; Sara Novi; Mario Felice Tecce; Anna Maria D'Ursi
Journal:  PLoS One       Date:  2020-04-16       Impact factor: 3.240

10.  Japanese patients with mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase deficiency: In vitro functional analysis of five novel HMGCS2 mutations.

Authors:  Yasuhiko Ago; Hiroki Otsuka; Hideo Sasai; Elsayed Abdelkreem; Mina Nakama; Yuka Aoyama; Hideki Matsumoto; Ryoji Fujiki; Osamu Ohara; Kazumasa Akiyama; Kaori Fukui; Yoriko Watanabe; Yoko Nakajima; Hidenori Ohnishi; Tetsuya Ito; Toshiyuki Fukao
Journal:  Exp Ther Med       Date:  2020-09-01       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.